Half of US drug trials and all vaccine trials failed to enlist elderly subjects

with No Comments
Photo: Solarisys/ Shutterstock

(Natalie Rahhal/ Daily Mail) — Americans over 65 were excluded from half of all US clinical trials of drugs and all trials for vaccines – including those for COVID-19 – from October of last year until June 1, 2020, new research reveals.

People over 65 are the most likely to develop severe COVID-19 and die of the devastating viral infection.

Yet they have been systematically left behind 50 percent of the time as scientists tried experimental therapies in trials of drugs for any condition, including those for coronavirus, like remdesivir, which might have saved the lives of thousands of older Americans.

Older people were left out of 100 percent despite the fact that they will likely be the first Americans to receive a shot once one is FDA-approved – far ahead of the young people vaccines were tested in. (…)

read full story